1228 related articles for article (PubMed ID: 28554875)
1. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
2. P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.
Savio LEB; Andrade MGJ; de Andrade Mello P; Santana PT; Moreira-Souza ACA; Kolling J; Longoni A; Feldbrügge L; Wu Y; Wyse ATS; Robson SC; Coutinho-Silva R
Mol Neurobiol; 2017 Oct; 54(8):6459-6470. PubMed ID: 27730511
[TBL] [Abstract][Full Text] [Related]
3. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
[TBL] [Abstract][Full Text] [Related]
5. NTPDase1 governs P2X7-dependent functions in murine macrophages.
Lévesque SA; Kukulski F; Enjyoji K; Robson SC; Sévigny J
Eur J Immunol; 2010 May; 40(5):1473-85. PubMed ID: 20201036
[TBL] [Abstract][Full Text] [Related]
6. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
7. CD39 improves survival in microbial sepsis by attenuating systemic inflammation.
Csóka B; Németh ZH; Törő G; Koscsó B; Kókai E; Robson SC; Enjyoji K; Rolandelli RH; Erdélyi K; Pacher P; Haskó G
FASEB J; 2015 Jan; 29(1):25-36. PubMed ID: 25318479
[TBL] [Abstract][Full Text] [Related]
8. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity.
Savio LEB; de Andrade Mello P; Santos SACS; de Sousa JC; Oliveira SDS; Minshall RD; Kurtenbach E; Wu Y; Longhi MS; Robson SC; Coutinho-Silva R
J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 32005701
[TBL] [Abstract][Full Text] [Related]
10. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells.
Kuhny M; Hochdörfer T; Ayata CK; Idzko M; Huber M
Cell Commun Signal; 2014 Jul; 12():40. PubMed ID: 25184735
[TBL] [Abstract][Full Text] [Related]
11. Purinergic dysregulation in pulmonary hypertension.
Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
[TBL] [Abstract][Full Text] [Related]
12. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
Shuai C; Xia GQ; Yuan F; Wang S; Lv XW
Eur J Pharmacol; 2021 Aug; 905():174198. PubMed ID: 34033815
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice.
Hoque R; Sohail MA; Salhanick S; Malik AF; Ghani A; Robson SC; Mehal WZ
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1171-9. PubMed ID: 22383490
[TBL] [Abstract][Full Text] [Related]
14. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
15. TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses.
Cohen HB; Briggs KT; Marino JP; Ravid K; Robson SC; Mosser DM
Blood; 2013 Sep; 122(11):1935-45. PubMed ID: 23908469
[TBL] [Abstract][Full Text] [Related]
16. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.
Liu ZN; Jia WQ; Jiang T; Dai JW; Shuai C; Lv XW
Int Immunopharmacol; 2019 Dec; 77():105915. PubMed ID: 31639617
[TBL] [Abstract][Full Text] [Related]
18. P2X7 receptor deletion attenuates oxidative stress and liver damage in sepsis.
Larrouyet-Sarto ML; Tamura AS; Alves VS; Santana PT; Ciarlini-Magalhães R; Rangel TP; Siebert C; Hartwig JR; Dos Santos TM; Wyse ATS; Takiya CM; Coutinho-Silva R; Savio LEB
Purinergic Signal; 2020 Dec; 16(4):561-572. PubMed ID: 33090332
[TBL] [Abstract][Full Text] [Related]
19. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
20. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
